Impact BioMedical Inc. (IBO) stock
IBONYSEPharmaceutical PreparationsFiscal year ends December 31
$3.06+0.38 (+14.18%)
Close on Oct 19, 2026Market cap $26.14MP/E –Yield –
Impact BioMedical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Impact BioMedical's profit margin for the twelve months ending Sep 30, 2026 was 4247.4%. For fiscal 2025 it was -36993.8%, against -14510.0% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -36993.8% | −22483.8 |
| FY2022 | Dec 31, 2022 | -14510.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -3071.4% | +5095.2 |
| Q2 FY2026 | Jun 30, 2026 | -23300.0% | +181642.9 |
| Q1 FY2026 | Mar 31, 2026 | -32671.4% | −31073.4 |
| Q4 FY2025 | Dec 31, 2025 | 74928.6% | – |
| Q3 FY2025 | Sep 30, 2025 | -8166.7% | – |
| Q2 FY2025 | Jun 30, 2025 | -204942.9% | – |
| Q2 FY2022 | Jun 30, 2022 | -1598.0% | – |
See a number that looks wrong?